Oscar Health, Inc. (NYSE:OSCR) Position Increased by Creative Planning

Creative Planning raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 73.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,296 shares of the company’s stock after buying an additional 13,286 shares during the period. Creative Planning’s holdings in Oscar Health were worth $664,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Avalon Trust Co bought a new stake in Oscar Health during the first quarter worth approximately $69,000. Point72 Hong Kong Ltd acquired a new position in Oscar Health in the 2nd quarter worth approximately $78,000. Quest Partners LLC acquired a new position in Oscar Health in the 2nd quarter worth approximately $93,000. Amalgamated Bank boosted its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the period. Finally, Farallon Capital Management LLC acquired a new position in Oscar Health in the 1st quarter worth approximately $164,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Up 5.1 %

Shares of NYSE OSCR opened at $17.65 on Monday. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of -135.77, a PEG ratio of 33.28 and a beta of 1.67. The business has a 50 day simple moving average of $18.74 and a 200 day simple moving average of $18.42. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. Oscar Health, Inc. has a 52 week low of $5.30 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same quarter in the prior year, the business posted ($0.07) EPS. Oscar Health’s quarterly revenue was up 44.6% on a year-over-year basis. On average, research analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on OSCR shares. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $24.00.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock valued at $3,007,069 over the last three months. 25.11% of the stock is currently owned by insiders.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.